UAE AI in Healthcare Market Outlook to 2030
By Use Case, By Care Setting, By Technology, By Deployment Model, By Buyer Type, and By Emirate
Report Overview
Report Code
TDR0363
Coverage
Middle East
Published
October 2025
Pages
80
Flexible Purchase Options
Select and purchase only the chapters you need for your strategic decisions
On This Page
Report Overview
Executive summary will be available soon.
Report Coverage
Verified Market Sizing
Multi-layer forecasting with historical data and 5–10 year outlook
Deep-Dive Segmentation
Cross-sectional analysis by product type, end user, application and region
Competitive Benchmarking & Positioning
Market share, operating model, pricing and competition matrices
Actionable Insights & Risk Assessment
High-growth white spaces, underserved segments, technology disruptions and demand inflection points
Review Methodology & Data Structure
Preview report structure, data sources and research framework
Executive Summary
Explore Flexible Purchase Options or Have Limited Budget?
Pay only for relevant chapters • Customizable report sections
Table of Contents
Choose individual sections to purchase. Mix and match as you like.
4.1 Delivery Model Analysis for AI in Healthcare (on-premise, sovereign cloud, hybrid, edge inference)-margins, preference, strengths & weaknesses
4.2 Revenue Streams for UAE AI in Healthcare Market (per-study licensing, enterprise subscription, outcome-based contracts, bundled with PACS/EHR, AI marketplace add-ons)
4.3 Business Model Canvas for UAE AI in Healthcare Market
5.1 AI Startups & Local Innovators vs Multinational Vendors
5.2 Investment Model in UAE AI in Healthcare Market (sovereign funds, PPPs, VC, corporate venture arms, sandboxes)
5.3 Comparative Analysis of AI Adoption Funnel by Public vs Private Providers
5.4 Budget Allocation for AI & Digital Health by Hospital Size/Ownership
8.1 Revenues (Historical, In USD Bn & AED)
9.1 By Market Structure (Public vs Private Hospitals; In-house vs Outsourced AI Solutions)
9.2 By Use Case (Imaging AI, Clinical Decision Support, NLP & Scribes, RCM & Claims Analytics, Operational AI Command Centers)
9.3 By Healthcare Verticals (Radiology, Cardiology, Oncology, Pathology, Emergency Medicine, Population Health)
9.4 By Provider Size (Large multispecialty hospitals, Medium hospitals, Diagnostic chains, Clinics & Ambulatory centers)
9.5 By End-User Designation (Radiologists, Pathologists, Emergency Physicians, Hospital Admins, Payers)
9.6 By Mode of Deployment (On-premise, Cloud, Edge, Hybrid)
9.7 By Customization Level (Standardized vs Customized AI models)
9.8 By Emirate (Abu Dhabi, Dubai, Sharjah, Northern Emirates)
10.1 Provider Client Landscape & Cohort Analysis
10.2 Decision-Making Process for AI Procurement (CIO, CMIO, Radiology Leads, Procurement Committees)
10.3 AI ROI & Effectiveness Framework (LOS reduction, reporting turnaround time, denial reduction, AED savings)
10.4 Gap Analysis Framework (demand for validated Arabic datasets, shortage of annotated imaging data, edge AI gaps)
11.1 Trends & Developments in UAE AI in Healthcare Market
11.2 Growth Drivers (HIE coverage, PDPL enforcement, imaging backlog, medical tourism demand, sovereign AI investments)
11.3 SWOT Analysis
11.4 Issues & Challenges (integration with legacy RIS/PACS, physician trust, fragmented regulatory approvals)
11.5 Government Regulations & Policies (PDPL, ADHICS, DOH AI approval frameworks, cloud residency laws)
12.1 Market Size & Future Potential for Online AI-enabled Telehealth & Diagnostics
12.2 Business Models & Revenue Streams (subscription tele-AI, per-scan analysis, pay-per-consult)
12.3 Delivery Models & Types of AI-powered Solutions Offered (virtual triage, AI-powered tele-radiology, chronic care management)
15.1 Market Share of Key Players (Basis Revenues in UAE AI Healthcare Market)
15.2 Benchmark of Key Competitors (Company Overview, USP, Business Strategies, Business Model, Number of Deployments, Revenues, Pricing, Technology Stack, Best-selling Solutions, Strategic Tie-ups, Recent Developments)
15.3 Operating Model Analysis Framework
15.4 Gartner Magic Quadrant Mapping (AI in Healthcare Vendors, UAE/Regional Presence)
15.5 Bowman’s Strategic Clock for Competitive Advantage
16.1 Revenues (Projections in USD Bn & AED)
17.1 By Market Structure (Public vs Private; In-house vs Outsourced)
17.2 By Use Case (Imaging, CDS, NLP, RCM, Ops AI)
17.3 By Healthcare Verticals (Radiology, Oncology, Pathology, Cardiology, Population Health)
17.4 By Provider Size
17.5 By End-User Designation
17.6 By Deployment Mode
17.7 By Customization Level
17.8 By Emirate
Discuss a Customized Research Scope
Custom research scope • Tailored insights • Industry expertise
Research Methodology
Step 1: Ecosystem Creation
We begin by mapping the entire UAE AI in Healthcare ecosystem, identifying both demand-side and supply-side entities. On the demand side, this includes public provider networks (SEHA, DHA, MOHAP hospitals), private healthcare groups (Aster, Mediclinic, NMC, Burjeel), payers and TPAs (Daman, private insurers), and government health information exchanges (Malaffi, NABIDH). On the supply side, we track multinational medtech and AI firms (Siemens, GE, Philips), regional startups (G42 Healthcare/M42, Prognica Labs), cloud vendors (G42 Cloud, Azure, AWS), and academic R&D hubs (MBZUAI, Khalifa University). Based on this mapped ecosystem, we shortlist 5–6 leading AI healthcare providers in the country using financial disclosures, deployment reach, and client partnerships as core evaluation criteria. Sourcing for this step is conducted through UAE Ministry of Health reports, emirate-level health authority publications, press releases, and proprietary databases.
Step 2: Desk Research
Next, we conduct exhaustive desk research, referencing a mix of secondary and proprietary databases to capture industry-level insights. This includes analyzing healthcare system statistics from MOHAP and World Bank datasets, regulatory frameworks such as PDPL and ADHICS, and AI adoption benchmarks from official UAE government portals. We aggregate insights on deployment volumes, provider readiness, vendor presence, and adoption barriers. Company-level data—sourced from press releases, annual reports, government filings, and clinical validation studies—are reviewed to evaluate partnerships, revenue streams, and footprint in UAE hospitals. This step allows us to construct a foundational understanding of the market structure, demand dynamics, and the positioning of active entities.
Step 3: Primary Research
To validate hypotheses and ground-truth secondary insights, we conduct in-depth interviews with C-level executives and decision makers from hospital networks, regulatory authorities, and AI solution providers. These include CIOs, CMIOs, radiology chiefs, and digital health directors across Abu Dhabi, Dubai, and Sharjah hospitals. Vendors such as imaging AI companies and cloud partners are also engaged. Disguised interviews are conducted under the guise of prospective clients to validate operational details such as AI module pricing models (per-scan vs. subscription), integration processes, and compliance workflows. This approach helps us triangulate financial and operational data against secondary sources, while uncovering detailed perspectives on adoption bottlenecks, value-chain workflows, and ROI perceptions across the UAE’s provider landscape.
Step 4: Sanity Check
The final step involves applying both bottom-to-top and top-to-bottom modeling to validate market estimates. Bottom-up analysis aggregates deployment volumes (e.g., imaging study loads, hospital bed counts, provider facility counts), while top-down analysis aligns estimates with UAE macroeconomic indicators such as GDP in current USD (USD 537.08 billion) and health system activity (MOHAP-reported 25.6 million hospital visits). Cross-verification ensures logical coherence between hospital-level adoption data and national-level projections. This combined approach delivers a balanced and validated market size model for the UAE AI in Healthcare market.
See What's Inside the Report
Get a preview of key findings, methodology and report coverage
Frequently Asked Questions
01 What is the potential for the UAE AI in Healthcare Market?
The UAE AI in Healthcare Market is positioned for substantial expansion, supported by strong government digitization strategies and large-scale healthcare modernization programs. With GDP reaching USD 537.08 billion (World Bank, 2024) and a population of 10.67 million (World Bank, 2024), the country has the economic and demographic foundation to scale AI across hospitals, diagnostics, and payer systems. The market’s potential is further amplified by initiatives like Malaffi and NABIDH, which have already connected 3.5 billion and 9.47 million patient records respectively, ensuring a ready infrastructure for AI adoption.
02 Who are the Key Players in the UAE AI in Healthcare Market?
The UAE AI in Healthcare Market features leading multinational and regional players. Key participants include Siemens Healthineers, GE Healthcare, Philips, Agfa HealthCare, Sectra, InterSystems, Oracle Health (Cerner), Aidoc, Qure.ai, Viz.ai, Annalise.ai, Lunit, G42 Healthcare (M42), Prognica Labs, and Altibbi. These companies dominate due to their deep clinical validation, integration with hospital IT systems, strong UAE partnerships, and focus on specialized use cases such as imaging AI, clinical decision support, pathology, and Arabic-language health AI.
03 What are the Growth Drivers for the UAE AI in Healthcare Market?
Growth is underpinned by multiple macroeconomic and structural factors. Healthcare capacity continues to rise, with 25.6 million hospital visits and 3.59 million emergency visits reported (MOHAP, 2023). Digital adoption is reinforced by the UAE’s 199.424 mobile subscriptions per 100 people (World Bank, 2024), enabling connected care and remote AI services. Strong policy direction from the UAE Artificial Intelligence Strategy and Abu Dhabi’s investment in genomics and precision medicine (via G42 and MBZUAI) further fuel adoption. Medical tourism inflows of 691,000 international patients in Dubai also accelerate demand for AI-enabled specialty care.
04 What are the Challenges in the UAE AI in Healthcare Market?
The market faces structural and operational challenges. First, a limited clinical workforce of 31,844 doctors and 65,510 nurses (MOHAP, 2023) constrains capacity to validate, adopt, and scale AI effectively. Second, fragmented data environments across emirates—Malaffi in Abu Dhabi and NABIDH in Dubai—create technical and governance barriers for unified AI deployment. Third, compliance with regulations such as PDPL (Federal Decree-Law No. 45 of 2021) and Abu Dhabi’s ADHICS security standards adds complexity and costs, requiring all 7,029 healthcare facilities to maintain stringent privacy, cybersecurity, and licensing frameworks before deploying AI solutions.
License Options
PDF + Excel
Complete report package
$4,000
Excel Only
Data and analytics
$2,500
Custom Sections
Starts from $100
$0